News

Personalis outlines $70M–$80M revenue target for 2025 amid 59% sequential clinical test growth and revised biopharma outlook
Discover key insights from Personalis Inc.'s Q2 2025 earnings call, including clinical growth, NeXT Personal adoption, Tempus partnership, and ...